Net Cash Provided by (Used in) Financing Activities in USD of ABVC BIOPHARMA, INC. from 2010 to Q1 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Abvc Biopharma, Inc. quarterly/annual Net Cash Provided by (Used in) Financing Activities history and change rate from 2010 to Q1 2025.
  • Abvc Biopharma, Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2025 was $429K, a 53.6% decline year-over-year.
  • Abvc Biopharma, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2024 was $1.98M, a 48.8% decline from 2023.
  • Abvc Biopharma, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2023 was $3.87M, a 3.59% decline from 2022.
  • Abvc Biopharma, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was $4.01M, a 59.8% decline from 2021.
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Change (%)
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Change (%)

ABVC BIOPHARMA, INC. Quarterly Net Cash Provided by (Used in) Financing Activities (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2025 $429K -$495K -53.6% Jan 1, 2025 Mar 31, 2025 10-Q 2025-04-30
Q1 2024 $924K -$1.28M -58.1% Jan 1, 2024 Mar 31, 2024 10-Q 2025-04-30
Q1 2023 $2.21M Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-17
Q1 2021 $42.2K -$568K -93.1% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
Q1 2020 $610K -$763K -55.6% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-10
Q1 2019 $1.37M +$1.02M +293% Jan 1, 2019 Mar 31, 2019 10-Q 2020-06-29
Q1 2018 $350K -$600K -63.2% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-28
Q1 2017 $950K Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-15
Q4 2014 $0 $0 Oct 1, 2014 Dec 31, 2014 10-Q 2015-04-17
Q3 2014 $71.4K Sep 19, 2014 Sep 30, 2014 10-K 2015-11-27
Q4 2013 $0 -$25K -100% Oct 1, 2013 Dec 31, 2013 10-Q 2015-04-17
Q4 2012 $25K -$318K -92.7% Oct 1, 2012 Dec 31, 2012 10-Q 2015-04-17
Q4 2011 $343K +$171K +99.5% Oct 1, 2011 Dec 31, 2011 10-Q 2015-04-16
Q4 2010 $172K Oct 1, 2010 Dec 31, 2010 10-Q 2012-02-21

ABVC BIOPHARMA, INC. Annual Net Cash Provided by (Used in) Financing Activities (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $1.98M -$1.89M -48.8% Jan 1, 2024 Dec 31, 2024 10-K 2025-04-15
2023 $3.87M -$144K -3.59% Jan 1, 2023 Dec 31, 2023 10-K 2025-04-15
2022 $4.01M -$5.98M -59.8% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-13
2021 $10M +$428K +4.47% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-31
2020 $9.57M +$6.48M +210% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-31
2019 $3.09M +$2.19M +244% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-16
2018 $897K -$663K -42.5% Jan 1, 2018 Dec 31, 2018 10-K 2020-05-15
2017 $1.56M -$1.09M -41.2% Jan 1, 2017 Dec 31, 2017 10-K 2019-04-15
2016 $2.65M +$2.65M Oct 1, 2015 Sep 30, 2016 10-KT 2018-04-13
2015 $0 $0 Oct 1, 2014 Sep 30, 2015 10-K 2015-11-27
2014 $0 -$25K -100% Oct 1, 2013 Sep 18, 2014 10-K 2015-11-27
2013 $25K -$851K -97.1% Oct 1, 2012 Sep 30, 2013 10-K 2015-04-16
2012 $876K -$825K -48.5% Oct 1, 2011 Sep 30, 2012 10-K 2015-04-16
2011 $1.7M +$639K +60.2% Oct 1, 2010 Sep 30, 2011 10-K 2015-04-15
2010 $1.06M Oct 1, 2009 Sep 30, 2010 10-K/A 2011-12-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.